Answers are grounded in this paper and cite their sources.
Highlights the ongoing issue of adverse drug reactions and under-reporting in primary healthcare, suggesting systemic solutions may be more effective than personalized medicine.
Adverse drug reactions. As medications get more complex, and multimorbidity rises, adverse drug reactions (ADRs) will undoubtedly continue to cause significant human and economic harms for decades to come. A recent scoping review from Australia identified a total of 19 articles published over a 15-year period that primarily focused on different types of ADRs in primary healthcare. The authors additionally highlighted the issue of under-reporting, especially in children, which they consider to be a major threat to patient safety. Their suggestion that personalised medicine and pharmacogenomics is the solution to minimising ADRs is laudable, but perhaps misses some more obvious and systemic solutions to improve current systems and practices.
No takes yet. Share an insight, caveat, or question.
Ahmed Rashid (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: